Alumis ALMS
NASDAQ ALMS
$11.09 -0.27 (-2.38%)
As of: Sep 4, 2026 · 3:22 PM EDT

Alumis (ALMS) Cash & Equivalents (2023 - 2026)

Alumis (ALMS) posted quarterly Cash & Equivalents of $89.7 million for Q4 2025, down 47.11% year-over-year from $169.5 million in Q4 2024, and up 37.41% quarter-over-quarter from $65.3 million in Q3 2025.

Analysis

Alumis (ALMS) Cash & Equivalents (2023 - 2026) Analysis & Trends

Alumis (ALMS) has reported Cash & Equivalents for 3 consecutive years, with $89.7 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Cash & Equivalents fell 47.11% year-over-year to $89.7 million; the TTM figure through Dec 2025 stood at $89.7 million (down 47.11% YoY), while the FY2025 annual figure was $89.7 million, down 47.11% from the prior year.
  • Cash & Equivalents climbed to $89.7 million in Q4 2025 per ALMS's latest filing, from $65.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $213.4 million in Q3 2024 and bottomed at $46.0 million in Q4 2023.
  • Historically, Cash & Equivalents has averaged $115.0 million across 3 years, with a median of $112.1 million in 2024.
  • Annual changes were most pronounced in 2024 — Cash & Equivalents soared 295.68% — and 2025, when it tumbled 69.42%.
  • Alumis' Cash & Equivalents stood at $46.0 million in 2023, then soared by 268.57% to $169.5 million in 2024, then sank by 47.11% to $89.7 million in 2025.
  • Business Quant data shows ALMS's Cash & Equivalents at $89.7 million in Q4 2025, $65.3 million in Q3 2025, and $151.8 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn 3.58 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 1.72 Bn
5 Revolution Medicines 43.98 Bn 43.98 Bn - 815.44 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 1.71 Bn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 811.99 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 544.80 Mn
10 Alumis 1.41 Bn 912.61 Mn - 63.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.71 Mn
Dec 31, 2025 89.67 Mn
Sep 30, 2025 65.26 Mn
Jun 30, 2025 151.75 Mn
Mar 31, 2025 128.54 Mn
Dec 31, 2024 169.53 Mn
Sep 30, 2024 213.42 Mn
Jun 30, 2024 155.11 Mn
Mar 31, 2024 112.07 Mn
Dec 31, 2023 46.00 Mn
Sep 30, 2023 53.94 Mn
Jun 30, 2023 79.56 Mn